雜志介紹

Journal Of Clinical Immunology雜志介紹

《Journal Of Clinical Immunology》是一本以English為主的未開放獲取國際優(yōu)秀期刊，中文名稱臨床免疫學雜志，本刊主要出版、報道醫(yī)學-IMMUNOLOGY領域的研究動態(tài)以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業(yè)的最新進展，探討行業(yè)發(fā)展的思路和方法，以促進學術信息交流，提高行業(yè)發(fā)展。該刊已被國際權威數據庫SCIE收錄，為該領域相關學科的發(fā)展起到了良好的推動作用，也得到了本專業(yè)人員的廣泛認可。該刊最新影響因子為7.2，最新CiteScore 指數為12.2。

本刊近期中國學者發(fā)表的論文主要有：

• De Novo Somatic Mosaicism of CYBB Caused by Intronic LINE-1 Element Insertion Resulting in Chronic Granulomatous Disease

  Author: Yu, Lang; Li, Wenhui; Lv, Ge; Sun, Gan; Yang, Lu; Chen, Junjie; Zhou, Lina; Ding, Yuan; Zhang, Zhiyong; Tang, Xuemei; An, Yunfei; Zhao, Xiaodong

• A Novel RAC2 Mutation Causing Combined Immunodeficiency

  Author: Zhang, Liang; Lv, Ge; Peng, Yu; Yang, Lu; Chen, Junjie; An, Yunfei; Zhang, Zhiyong; Tang, Xuemei; Li, Zhihui; Zhao, Xiaodong

• Pathogenic Interleukin-10 Receptor Alpha Variants in Humans - Balancing Natural Selection and Clinical Implications

  Author: Aschenbrenner, Dominik; Ye, Ziqing; Zhou, Ying; Hu, Wenhui; Brooks, Isabel; Williams, Isabelle; Capitani, Melania; Gartner, Lisa; Kotlarz, Daniel; Snapper, Scott B.; Klein, Christoph; Muise, Aleixo M.; Marsden, Brian D.; Huang, Ying; Uhlig, Holm H.

• The Clinical Significance and Prognostic Role of Whole-Blood Epstein-Barr Virus DNA in Lymphoma-Associated Hemophagocytic Lymphohistiocytosis

  Author: Zhang, Jing; Qin, Shuchao; Jin, Ze; Chen, Qingqing; Xing, Lingxiao; Qiu, Tonglu; Xia, Yi; Liang, Jinhua; Zhu, Huayuan; Wang, Li; Fan, Lei; Xu, Wei; Li, Jianyong; Miao, Yi

英文介紹

Journal Of Clinical Immunology雜志英文介紹

The Journal of Clinical Immunology publishes high impact papers in the area of human immunology that explore the diagnosis, pathogenesis, prognosis, or treatment of human diseases. The Journal is particularly focused on primary immunodeficiencies and related diseases. These include inborn errors of immunity, in the broad sense of the term, their underlying genotypes and their diverse phenotypes, including infection, malignancy, allergy, auto-inflammation, and autoimmunity. We consider a wide range of studies in this area, ranging from genetic discovery, clinical description, immunologic assessment, diagnostic approach, prognosis evaluation, and treatment intervention. Case reports are considered if they are truly original and are accompanied by a succinct review of the relevant medical literature and how the novel case study advances the field. The four categories of papers are detailed in the instructions to authors.